Gestational Diabetes Mellitus (GDM) is a type of diabetes that affects some people during pregnancy and is sometimes referred to as ‘pregnancy induced diabetes’. The body’s need for insulin (a hormone that helps sugar get into the cells) increases during pregnancy, and GDM can occur when the body cannot make enough insulin. Having GDM during pregnancy can increase the risk of other pregnancy complications, such as having a larger sized baby, pre-eclampsia (a condition that causes high blood pressure) and having a Caesarean section birth. Current data on the best timing for induction of labour for patients with GDM is inconclusive. International guidelines differ in timing of induction of labour, varying from 37-weeks to 39-weeks of pregnancy. A randomized control trial would allow us to assess the outcomes associated with the induction of labour at 38-weeks’ gestation compared to current expectant management.
To help inform and develop the design of a future clinical trial, our research team would like to gain insight from patients and health care providers to assess their opinions in participating or supporting a clinical trial to evaluate induction of labour at 38-weeks’ gestation compared to current expectant management in those pregnancies with GDM.
The OMNI Research Group is proudly affiliated with